Caio Bracey

Matching patients with the ever-expanding range of TAVI devices

Latest Reviews

  • Review |

    Cardiovascular mortality among the almost 600 million people living in the Eastern Mediterranean region (EMR) has been proposed to increase more dramatically in the next decade than in any other region except Africa. Turk-Adawi and colleagues summarize the available data on cardiovascular disease burden, risk factors, and treatment modalities for the EMR population.

    • Karam Turk-Adawi
    • , Nizal Sarrafzadegan
    • , Ibtihal Fadhil
    • , Kathryn Taubert
    • , Masoumeh Sadeghi
    • , Nanette K. Wenger
    • , Nigel S. Tan
    •  & Sherry L. Grace
  • Review |

    This Review summarizes the latest findings on heart reverse remodelling, which demonstrate that despite apparent normalization of function, the molecular changes associated with heart failure persist in the reverse-remodelled heart. This myocardial remission is distinct from true recovery, in which both function and molecular makeup are normalized. These findings have implications for developing therapies to repair the failing heart.

    • Gene H. Kim
    • , Nir Uriel
    •  & Daniel Burkhoff
  • Review |

    Over the past decade, marijuana has been legalized for medicinal purposes or recreational use in many countries, and the potency of marijuana and synthetic cannabinoids has substantially increased. In this Review, Pacher and colleagues summarize the role of the endocannabinoid system in cardiovascular health and disease, and critically discuss the beneficial and detrimental cardiovascular effects of marijuana and synthetic cannabinoid use.

    • Pal Pacher
    • , Sabine Steffens
    • , György Haskó
    • , Thomas H. Schindler
    •  & George Kunos
  • Consensus Statement | | open

    A range of drugs is available for symptomatic angina, but the optimal choice or combination of therapies is often uncertain, and contemporary guidelines do not necessarily provide definite recommendations. In this Consensus Statement, Ferrari and colleagues propose an individualized approach to angina treatment, which takes into consideration the patient, their comorbidities, and the underlying mechanism of disease.

    • Roberto Ferrari
    • , Paolo G. Camici
    • , Filippo Crea
    • , Nicolas Danchin
    • , Kim Fox
    • , Aldo P. Maggioni
    • , Athanasios J. Manolis
    • , Mario Marzilli
    • , Giuseppe M. C. Rosano
    •  & José L. Lopez-Sendon
  • Review |

    Sudden infant death syndrome (SIDS) is the leading cause of infant mortality in developed countries. In this Review, Behr and colleagues provide an update on the spectrum and prevalence of the subset of SIDS mediated by cardiogenetic factors, and the clinical implications of SIDS in the surviving family and general population.

    • Alban-Elouen Baruteau
    • , David J. Tester
    • , Jamie D. Kapplinger
    • , Michael J. Ackerman
    •  & Elijah R. Behr
  • Review |

    A growing body of evidence supports the role of the gut microbiota in regulating blood pressure. In their Review, Marques and co-workers describe how the gut microbiota and its metabolites act on downstream cellular targets to influence the pathogenesis of hypertension. Novel strategies to modify the gut microbiota might present a new therapeutic avenue to improve health and prevent disease.

    • Francine Z. Marques
    • , Charles R. Mackay
    •  & David M. Kaye

News & Comment

Natureevents Directory